(R)-carnitine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on triglycerides
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Similarly, FBS, TG, and HDLc with L-carnitine intervention presented no significant difference between the intervention and control groups.”
Quoted verbatim from L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- 0.75 to 3 g/day across included RCTs, 8 to 24 weeks
- Population
- Adults in nine RCTs (diabetes mellitus, non-alcoholic steatohepatitis, knee osteoarthritis, hemodialysis); six RCTs contributed TG data; whole-population estimate
L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2020PMID:32932644Permalink
Keep reading
- Everything the graph holds on (R)-carnitine
- Every compound studied against Triglycerides
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45QKTXW06RQ2HGTCAH9KGW6